Literature DB >> 31335478

Impact of a National Private Health Insurer's Prior Authorization Policy on Utilization of Vaginal Hysterectomy.

Carolyn W Swenson1, Neil S Kamdar, Kristian Seiler2, Daniel M Morgan1.   

Abstract

OBJECTIVES: On April 6, 2015, the largest private health insurer in the United States implemented a policy requiring prior authorization for all hysterectomies except those done as outpatient vaginal. The purpose of this policy was to increase utilization of vaginal hysterectomy; however, it is unknown whether this policy had its intended effect. We sought to analyze trends in hysterectomy routes before and after implementation of the prior authorization policy to see if utilization of vaginal hysterectomy increased.
METHODS: This was a retrospective study using the Optum Clinformatics Data Mart national claims database of women enrolled in a single national private health insurer who underwent hysterectomy for any indication between January 1, 2010, and June 30, 2016. Per-quarter utilization of hysterectomy routes (abdominal, laparoscopic, vaginal, and laparoscopic-assisted vaginal) was compared between the prepolicy and postpolicy periods using interrupted time series analyses.
RESULTS: Data for 305,139 hysterectomies were available-248,821 in the prepolicy period and 56,318 in the postperiod. Outpatient vaginal hysterectomy had the greatest increase in utilization of all routes and types; the average utilization per quarter in the prepolicy period was -0.61%, and this increased to 0.21% in the postpolicy period (P < 0.0001). Outpatient laparoscopic hysterectomy had the greatest decrease in utilization, with an average decrease of -1.50% per quarter.
CONCLUSIONS: The prior authorization policy was associated with a short-term increase in utilization of vaginal hysterectomy.
Copyright © 2019 American Urogynecologic Society. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 31335478      PMCID: PMC6800593          DOI: 10.1097/SPV.0000000000000729

Source DB:  PubMed          Journal:  Female Pelvic Med Reconstr Surg        ISSN: 2151-8378            Impact factor:   1.913


  13 in total

1.  An update on inpatient hysterectomy routes in the United States.

Authors:  Vrunda B Desai; Xiao Xu
Journal:  Am J Obstet Gynecol       Date:  2015-07-28       Impact factor: 8.661

2.  Alterations in surgical technique after FDA statement on power morcellation.

Authors:  Vrunda B Desai; Xiaoyue M Guo; Xiao Xu
Journal:  Am J Obstet Gynecol       Date:  2015-02-28       Impact factor: 8.661

Review 3.  Interventions Aimed at Reducing Use of Low-Value Health Services: A Systematic Review.

Authors:  Carrie H Colla; Alexander J Mainor; Courtney Hargreaves; Thomas Sequist; Nancy Morden
Journal:  Med Care Res Rev       Date:  2016-07-08       Impact factor: 3.929

4.  Impact of restricting diagnostic imaging reimbursement for uncomplicated low back pain in Ontario: a population-based interrupted time series analysis.

Authors:  Benjamin Fine; Susan E Schultz; Lawrence White; David Henry
Journal:  CMAJ Open       Date:  2017-10-13

5.  Committee Opinion No 701: Choosing the Route of Hysterectomy for Benign Disease.

Authors: 
Journal:  Obstet Gynecol       Date:  2017-06       Impact factor: 7.661

6.  Nationwide trends in the utilization of and payments for hysterectomy in the United States among commercially insured women.

Authors:  Daniel M Morgan; Neil S Kamdar; Carolyn W Swenson; Emily K Kobernik; Anne G Sammarco; Brahmajee Nallamothu
Journal:  Am J Obstet Gynecol       Date:  2017-12-26       Impact factor: 8.661

7.  Impact of a limited fluoroquinolone reimbursement policy on antimicrobial prescription claims.

Authors:  M E MacCara; I S Sketris; D G Comeau; S D Weerasinghe
Journal:  Ann Pharmacother       Date:  2001 Jul-Aug       Impact factor: 3.154

8.  Nationwide trends in the performance of inpatient hysterectomy in the United States.

Authors:  Jason D Wright; Thomas J Herzog; Jennifer Tsui; Cande V Ananth; Sharyn N Lewin; Yu-Shiang Lu; Alfred I Neugut; Dawn L Hershman
Journal:  Obstet Gynecol       Date:  2013-08       Impact factor: 7.661

9.  Regression based quasi-experimental approach when randomisation is not an option: interrupted time series analysis.

Authors:  Evangelos Kontopantelis; Tim Doran; David A Springate; Iain Buchan; David Reeves
Journal:  BMJ       Date:  2015-06-09

Review 10.  Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs.

Authors:  Daniël Lakens
Journal:  Front Psychol       Date:  2013-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.